MRK vs SYF · P/E 33, rev $16.61B vs rev $11.19B
Merck & Company Inc (MRK) versus SYF (SYF) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
SYF (SYF) common stock.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported SYF revenue for 2026-06-30 was $11.19B. Net income was $1.69B. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. SYF currently screens at market cap $0.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. SYF currently screens at market cap $0.
Not investment advice. Open the MRK and SYF stock pages for the full models.
Not investment advice.